How many institutions own GRI stock?

A company's 13F filings with the Securities and Exchange Commission (SEC) provides investors with comprehensive information about institutional ownership in a listed company, a sign of strength in terms of how many institutions have confidence in that company. The number of institutional investors who currently own GRI shares is 5, representing 0.78% of the company's common stock.

Who are the major shareholders selling GRI Bio, Inc. stock?

N/A, in the last quarter, reduced its stake in GRI by N/A restricting it's holding to - shares of worth nearly -. N/A also lessened N/A of the GRI shares from its portfolio, reducing its holding to - shares of worth -. N/A also shunned GRI shares holding by N/A last quarter which brought its holding to - shares worth -.

Investors who are buying GRI stock?

As per its latest 13F filing, N/A increased its stake in GRI by N/A in the last quarter. The institutional holder raised its holding to - shares having worth more than -. N/A also added N/A more shares of GRI to its portfolio, raising its holding to - shares of worth -. N/A also increased its GRI shares holding by N/A which brought its holding to - shares worth -.

GRI's major insiders: who are they?

The insider with the most stakes in GRI is Hertz Walter Marc , Chief Executive Officer at the company. Additionally, GRI stock is highly held by Chief Scientific Officer Chaturvedi Vipin and Chief Medical Officer Agro Albert among others.

Did an insider recently sell GRI stock?

Company executives, directors, and other insiders own 0.02% percent of GRI Bio, Inc.'s stock. Within the last six months, there have been 0 transaction(s) in which GRI insiders have sold stock, totaling 0 shares. Insiders that have sold shares include .

Which insider recently purchased GRI stock?

There have been 0 transaction(s) during the past 6-months in which GRI Bio, Inc. insiders have bought stock, totalling 0 shares

How much of GRI does insiders own?

Around 0 GRI Bio, Inc. shares are held by insiders, which represents about 0.02% of GRI stock.

Who is the insider with the largest stake?

GRI Chief Executive Officer, Hertz Walter Marc holds the largest portfolio of the company's shares. GRI shares owned by Hertz total nearly 385.51 thousand.

Which institution holds the most shares in GRI?

N/A is the largest institutional owner in GRI which holds - shares worth - or N/A of the total GRI shares outstanding followed by N/A with ownership of - shares representing N/A of the GRI ownership. N/A is the third largest stakeholder with - shares or N/A of the ownership worth more than -.

Is GRI Bio, Inc. stock optionable?

Stock options give the owner the ability but not the obligation to buy or sell a security at a predetermined price and date. Stock options can be classified into two types: puts and calls. A put is a bet on falling stock, and a call is a bet on rising stock. As far as the GRI is concerned, it is a stock which is not optionable.

Is there a short position on GRI's shares?

Number of GRI shares short is 178.17K. Shares short is a market sentiment in which investors have sold their shares short in a given stock but have not yet covered them or closed them out.

About how many outstanding GRI shares are there?

As of today, 2.52M shares of GRI are outstanding.

Is there many float in GRI stock?

Float represents the number of tradeable shares in a specific stock. By subtracting restricted and closely-held shares from a firm's total outstanding shares, we can calculate its floating stock. The term "closely-held shares" refers to shares held by employees, major shareholders, and company insiders. At present, GRI has 2.51M shares in float.

GRI short ratio: what is it?

Short ratio is calculated by dividing the number of short shares, short interest or bets that shareholders will sell short from the average daily volume. A higher ratio indicates longer times needed to repurchase borrowed shares (sold). The short ratio for GRI is 0.67.

Stock Ideas

GRI Stock Ownership Breakdown

NASDAQ : GRI

GRI Bio

$2.38

0.065+2.81%

At Close 4:00 PM

Profile Key Stats Analyst Ratings Ownership Ratios Financials Dividend & splits Sentiment Forecast

Stock Outstanding Shares

Making an investment decision in the stock market involves a certain amount of risk, so it's important to thoroughly review a company's stock before making any decisions. Stock float, number of short positions and outstanding shares are among the many factors an investor should take into account.

ShortableYes

OptionableNo

Short Percent Of Outstanding Shares7.14

Short Percent Of Float7.14

Shares Outstanding2.52M

Shares Float2.51M

Shares Short178.17K

Short Ratio0.67

7.14%

Short % of Float

7.14%

Short % of Shares Outstanding

Market Insider

Investors cannot turn a blind eye to insiders as well as institutional ownership. They need to follow insider trades to determine the direction the stock is likely to take.

Major Holders Summary

0.02% Percentage of Shares held by All Insiders

0.78% Percentage of Shares held by All Institutions

0.78% Percentage of Float held by Institutions

Number of Institutions Holding Shares

Institutional Ownership

Date	Holder	% Stake	Shares Held	Total Value ($)	Shares	% Change in Portfolio
No Data

Insiders

Among the GRI insiders holding of 0.02% of the stake in company, HERTZ WALTER MARC, Chief Executive Officer, holds the largest shares of 385.51K. CHATURVEDI VIPIN, Chief Scientific Officer, is the second largest GRI insider with ownership of 172.19K shares. AGRO ALBERT, Chief Medical Officer, stands third with possession of 172.19K shares of that stake.

Insiders	Designation	Shares Held
HERTZ WALTER MARC	Chief Executive Officer	385.51K
CHATURVEDI VIPIN	Chief Scientific Officer	172.19K
AGRO ALBERT	Chief Medical Officer	172.19K
KELLY LEANNE	Chief Financial Officer	83.33K
KELLY LEANNE M.	Chief Financial Officer	50K
SALMON PHARMA GMBH	10 percent owner	47.06K
SIMPSON CAMILLA V	director	34.48K
RONGEN ROELOF	director	34.48K
BAKER DAVID CHARLES	director	34.48K
SZEKERES DAVID LESLIE	director	34.48K
LEVI OFIR	director	30K
TOREN PENNY	SVP, Regul Affairs & Prog Mgmt	25K
CHHABRA MEENU	director	15K
THORELL MARELLA	director	9.51K
AMMER RICHARD	director	7.5K
PAYNE JOSEPH E	director	7.5K

Buying/Selling by Insiders

Date	Insider	Type	Cost	Shares	Value ($)	Shares Total
Sep 22, 2023	KELLY LEANNE	AWARD	1.52	83.33K	126.67K	83.33K
Aug 10, 2023	SZEKERES DAVID LESLIE	AWARD	2.90	34.48K	100K	34.48K
Aug 10, 2023	BAKER DAVID CHARLES	AWARD	2.90	34.48K	100K	34.48K
Aug 10, 2023	RONGEN ROELOF	AWARD	2.90	34.48K	100K	34.48K
Aug 10, 2023	SIMPSON CAMILLA V	AWARD	2.90	34.48K	100K	34.48K
Apr 21, 2023	CHATURVEDI VIPIN	AWARD	0.00	172.19K	-	172.19K
Apr 21, 2023	AGRO ALBERT	AWARD	0.00	172.19K	-	172.19K
Apr 21, 2023	HERTZ WALTER MARC	AWARD	0.00	385.51K	-	385.51K
Dec 13, 2022	THORELL MARELLA	OTHER	0.00	28.52K	-	9.51K
Jul 01, 2022	THORELL MARELLA	AWARD	0.00	38.02K	-	38.02K
Jun 09, 2022	THORELL MARELLA	AWARD	0.51	7.5K	3.83K	7.5K
Jun 09, 2022	PAYNE JOSEPH E	AWARD	0.51	7.5K	3.83K	7.5K
Jun 09, 2022	AMMER RICHARD	AWARD	0.51	7.5K	3.83K	7.5K
Feb 23, 2022	CHHABRA MEENU	AWARD	7.67	15K	115.05K	15K
Feb 15, 2022	KELLY LEANNE M.	AWARD	5.63	50K	281.5K	50K
Feb 15, 2022	BAKER DAVID CHARLES	AWARD	5.63	61K	343.43K	61K
Jun 04, 2021	KELLY LEANNE M.	PURCHASE	4.08	1.51K	6.15K	6.25K
Jun 03, 2021	KELLY LEANNE M.	PURCHASE	4.05	1.09K	4.39K	4.74K
Jun 02, 2021	KELLY LEANNE M.	PURCHASE	4.00	3.66K	14.63K	3.66K
May 26, 2021	PAYNE JOSEPH E	PURCHASE	4.50	6.8K	30.6K	17.5K
May 25, 2021	PAYNE JOSEPH E	PURCHASE	3.85	10.7K	41.2K	10.7K
May 14, 2021	BAKER DAVID CHARLES	AWARD	3.66	100K	366K	100K
May 14, 2021	TOREN PENNY	AWARD	3.66	25K	91.5K	25K
May 14, 2021	KELLY LEANNE M.	AWARD	3.66	70K	256.2K	70K
May 14, 2021	LEVI OFIR	AWARD	3.66	30K	109.8K	30K
May 14, 2021	AMMER RICHARD	AWARD	3.66	10.2K	37.35K	10.2K
May 14, 2021	PAYNE JOSEPH E	AWARD	3.66	14.29K	52.29K	14.29K
Feb 12, 2021	BAKER DAVID CHARLES	PURCHASE	8.00	1K	8K	8.84K
Feb 12, 2021	THORELL MARELLA	AWARD	8.00	15K	120K	15K
Feb 12, 2021	SALMON PHARMA GMBH	OTHER	6.40	47.06K	301.2K	47.06K
Feb 12, 2021	AMMER RICHARD	OTHER	6.40	47.06K	301.2K	47.06K

Frequently Asked Questions

Stocks Telegraph provides information and tools designed to assist investors and Wall Street players. A major goal is to offer financiers comprehensive information that will help them gain insight into investing.

Stocks Telegraph does not provide any advice or recommendations for buying or selling stocks, securities, or other financial products. Information contained on this website is for informational purposes only and should not be construed as professional financial, investment or other advice. Stocks Telegraph is not liable for any loss or damage that may occur as a result of reliance on this data.